Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment
Crossref DOI link: https://doi.org/10.1007/s00277-016-2662-6
Published Online: 2016-04-11
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
João, Cristina
Freitas, José
Gomes, Fernando
Geraldes, Catarina
Coelho, Inês
Neves, Manuel
Lúcio, Paulo
Esteves, Susana
Esteves, Graça V.
Text and Data Mining valid from 2016-04-11